Uruguay: Vaccine Market 2025

Vaccine Market Size in Uruguay

In 2022, the Uruguayan vaccine market decreased by -5.9% to $X for the first time since 2018, thus ending a three-year rising trend. Over the period under review, consumption, however, continues to indicate buoyant growth. Over the period under review, the market reached the peak level at $X in 2021, and then contracted in the following year.

Vaccine Production in Uruguay

In value terms, vaccine production amounted to $X in 2022 estimated in export price. Overall, production recorded a prominent increase. The most prominent rate of growth was recorded in 2013 with an increase of 30%. Vaccine production peaked at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Vaccine Exports

Exports from Uruguay

In 2021, after three years of decline, there was decline in shipments abroad of vaccines for human medicine, when their volume decreased by 0% to less than X kg. In general, exports enjoyed a prominent increase. The pace of growth was the most pronounced in 2016 when exports increased by 257% against the previous year. The exports peaked at X kg in 2017; however, from 2018 to 2021, the exports stood at a somewhat lower figure.

In value terms, vaccine exports totaled $X in 2021. Overall, exports continue to indicate a remarkable increase. The pace of growth was the most pronounced in 2014 with an increase of 128% against the previous year. The exports peaked at $X in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

Exports by Country

Ecuador (X kg) was the main destination for vaccine exports from Uruguay, accounting for a approx. 100% share of total exports.

From 2012 to 2018, the average annual growth rate of volume to Ecuador was relatively modest.

In value terms, Ecuador ($X) emerged as the key foreign market for vaccines for human medicine exports from Uruguay.

From 2012 to 2018, the average annual rate of growth in terms of value to Ecuador was relatively modest.

Export Prices by Country

In 2018, the average vaccine export price amounted to $X per ton, picking up by 55% against the previous year. In general, the export price, however, recorded a abrupt setback. The export price peaked at $X per ton in 2015; however, from 2016 to 2018, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for Ecuador.

From 2012 to 2018, the rate of growth in terms of prices for Pakistan amounted to -22.6% per year.

Vaccine Imports

Imports into Uruguay

In 2022, overseas purchases of vaccines for human medicine decreased by -30.2% to X tons for the first time since 2015, thus ending a six-year rising trend. Over the period under review, imports, however, showed a prominent expansion. The growth pace was the most rapid in 2021 when imports increased by 417% against the previous year. As a result, imports reached the peak of X tons, and then dropped remarkably in the following year.

In value terms, vaccine imports reduced dramatically to $X in 2022. In general, imports, however, recorded a significant increase. The most prominent rate of growth was recorded in 2021 when imports increased by 1,236% against the previous year. As a result, imports attained the peak of $X, and then shrank remarkably in the following year.

Imports by Country

India (X tons), the United States (X tons) and France (X tons) were the main suppliers of vaccine imports to Uruguay, together accounting for 33% of total imports. Belgium, South Korea, Panama, Italy, Ireland, the Netherlands and Switzerland lagged somewhat behind, together comprising a further 31%.

From 2012 to 2022, the biggest increases were recorded for Italy (with a CAGR of +60.1%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Ireland ($X) constituted the largest supplier of vaccines for human medicine to Uruguay, comprising 6.7% of total imports. The second position in the ranking was taken by the United States ($X), with a 2.4% share of total imports. It was followed by France, with a 2.2% share.

From 2012 to 2022, the average annual rate of growth in terms of value from Ireland totaled +12.0%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (+7.5% per year) and France (+13.6% per year).

Import Prices by Country

In 2022, the average vaccine import price amounted to $X per ton, shrinking by -23% against the previous year. Over the period under review, the import price, however, posted a buoyant increase. The pace of growth appeared the most rapid in 2021 when the average import price increased by 158%. As a result, import price attained the peak level of $X per ton, and then dropped significantly in the following year.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Ireland ($X per ton), while the price for South Korea ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Ireland (+17.0%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :